NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-HS-21-014 from the NIH Guide for Grants and Contracts
Notice NOT-NS-21-059 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-21-023 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences Mentoring Activities The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce. NIDDK's Short-Term Research Experience for Underrepresented Persons (STEP-UP) provides funding to research institutions to provide for a national summer research experience program for both high school and undergraduate students for eight to ten weeks. STEP-UP seeks to facilitate exposure opportunities for students from diverse backgrounds underrepresented in biomedical research on a national basis, including individuals from disadvantaged backgrounds, individuals from underrepresented racial and ethnic groups, and individuals with disabilities.
Notice NOT-AI-21-049 from the NIH Guide for Grants and Contracts
Notice NOT-TR-21-026 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-064 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-063 from the NIH Guide for Grants and Contracts
Notice NOT-OD-21-110 from the NIH Guide for Grants and Contracts
Notice NOT-AG-21-022 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-21-022 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from Small Business Concerns (SBCs) to pursue translational activities and small clinical studies to advance the development of therapeutic and diagnostic devices for disorders that affect the nervous or neuromuscular systems. The translational device activities, including translational bench and animal studies, are expected to lead to submission of an Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) or Institutional Review Board (IRB) application for a Non-Significant Risk (NSR) study. This cooperative agreement will also support the subsequent small clinical study to collect safety and effectiveness data required to support a marketing application or to inform final device design.
Funding Opportunity RFA-NS-21-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disorders that affect the nervous or neuromuscular systems. Activities supported in this program include implementation of clinical prototype devices, non-clinical safety and efficacy testing, design verification and validation activities, obtaining an Investigational Device Exemption (IDE) for a Significant Risk (SR) study or Institutional Review Board (IRB) approval for a Non-Significant Risk (NSR) study, as well as a subsequent small clinical study. The clinical study is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. This FOA is a milestone-driven cooperative agreement program and will involve participation of NIH program staff in negotiating the final project plan before award and monitoring of research progress.
Notice NOT-CA-21-071 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-22-001 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA), issued by the National Institute on Drug Abuse (NIDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications to develop mobile health technologies, including wearables and other digital health enabled technologies, to address existing digital inequalities affecting underserved and vulnerable populations suffering from Substance Use Disorders (SUD).
Notice NOT-HS-21-012 from the NIH Guide for Grants and Contracts
Notice NOT-HS-21-013 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AI-21-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the identification of mechanisms behind heterogeneous responses in the population to influenza infection and /or vaccination through development and application of computational tools.
Notice NOT-HL-21-011 from the NIH Guide for Grants and Contracts
Notice NOT-CA-21-070 from the NIH Guide for Grants and Contracts
Notice NOT-HD-21-025 from the NIH Guide for Grants and Contracts
Notice NOT-HD-21-026 from the NIH Guide for Grants and Contracts